Dendritic cell vaccination for hepatocellular carcinoma.

Dendritic cell vaccination for hepatocellular carcinoma.

Dades bibliogràfiques
Autors principals:	Midgley, R, Palmer, D, Mirza, N, Steele, J, Steven, J, Kerr, D, Young, L, Adams, D
Format:	Conference item
Publicat:	2003

Ítems similars

A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
per: Midgley, R, et al.
Publicat: (2002)

A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
per: Midgley, R, et al.
Publicat: (2004)

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
per: Palmer, D, et al.
Publicat: (2009)

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients
per: Sarah M. Bray, et al.
Publicat: (2011-01-01)

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
per: Wenya Li, et al.
Publicat: (2024-09-01)

Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
per: Li Z, et al.
Publicat: (2020-03-01)

EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
per: Yoo Jin Choi, et al.
Publicat: (2018-01-01)

Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
per: Xinning Zhang, et al.
Publicat: (2022-11-01)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
per: Jeong-Hoon Lee, et al.
Publicat: (2017-07-01)

In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
per: Sagawa Yukiko, et al.
Publicat: (2008-09-01)

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
per: Ye-Bin Pang, et al.
Publicat: (2019-01-01)

Identification of an oligopeptide binding to hepatocellular carcinoma.
per: Shimizu, A, et al.
Publicat: (2006)

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
per: Noessner Elfriede, et al.
Publicat: (2005-07-01)

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
per: Chiao-Fang Teng, et al.
Publicat: (2020-06-01)

Trial watch: dendritic cell vaccination for cancer immunotherapy
per: Jenny Sprooten, et al.
Publicat: (2019-11-01)

Dendritic Cell-Related Gene Signatures in Hepatocellular Carcinoma: An Analysis for Prognosis and Therapy Efficacy Evaluation
per: Huang H, et al.
Publicat: (2024-09-01)

Trial watch: anticancer vaccination with dendritic cells
per: Francisca Borges, et al.
Publicat: (2024-12-01)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
per: Daniels, H, et al.
Publicat: (2005)

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
per: Galea-Lauri, J, et al.
Publicat: (2004)

Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
Publicat: (2021-12-01)

Personalized Dendritic Cell Vaccines
per: Anzhelika Alexandrovna Melnikova, et al.
Publicat: (2023-10-01)

Dendritic Cell-Targeted Vaccines
per: Lelia eDelamarre, et al.
Publicat: (2014-05-01)

Neoantigens as potential vaccines in hepatocellular carcinoma
per: Kathrin Heim, et al.
Publicat: (2022-02-01)

Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
per: Fang-Zhu Ouyang, et al.
Publicat: (2016-11-01)

Comparative Analysis of Cytotoxic T Lymphocyte Response Induced by Dendritic Cells Loaded with Hepatocellular Carcinoma -Derived RNA or Cell Lysate
per: Ke Pan, Jing-jing Zhao, Hui Wang, Jian-jun Li, Xiao-ting Liang, Jian-cong Sun, Yi-bing Chen, Hai-qing Ma, Qing Liu, Jian-chuan Xia
Publicat: (2010-01-01)

The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
per: Joan Ericka Flores, et al.
Publicat: (2022-05-01)

Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma
per: Ngo DHA, et al.
Publicat: (2021-05-01)

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
per: Zecong Xiao, et al.
Publicat: (2023-03-01)

Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model
per: Shengbin Shi, et al.
Publicat: (2018-04-01)

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
per: Liu Y, et al.
Publicat: (2019-07-01)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
per: Xiaoqing Shi, et al.
Publicat: (2023-03-01)

Novel treatments for hepatocellular cancer.
per: Kerr, S, et al.
Publicat: (2009)

Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy
per: Marcos F. Dall'Oglio, et al.
Publicat: (2011-04-01)

THE ROLE OF INTRATUMORAL DENDRITIC CELLS IN THE PROGRESSION OF SQUAMOUS CELL CARCINOMAS
per: L. N. Bondar, et al.
Publicat: (2019-09-01)

Hepatocellular carcinoma diagnosis and treatment: An overview
per: Steven D. Colquhoun, et al.
Publicat: (2020-12-01)

Hepatocellular Carcinoma in Hereditary Hemochromatosis
per: Paul C Adams
Publicat: (1993-01-01)

Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances
per: Charneau J, et al.
Publicat: (2021-09-01)

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity
per: Jurjen Tel, et al.
Publicat: (2016-01-01)

Melanoma immunotherapy: dendritic cell vaccines
per: Ivan Lozada-Requena, et al.
Publicat: (2015-09-01)

Dendritic Cell Vaccines in Ovarian Cancer
per: Xi Zhang, et al.
Publicat: (2021-01-01)